- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06909786
Hypotension Prediction Index and Intraoperative Hypotension Incidence
Effect of Intraoperative Implementation of the Hypotension Prediction Index (HPI) Guided Management Strategy on Incidents of Intraoperative Hypotension Among Frail Patients Undergoing Major Abdominal Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Intraoperative hypotension (IOH) is common, a study involved 34,045 surgical patients in elective, emergency, and intensive care unit (ICU) found that the incidence of hypotension (defined as systolic blood pressure below 80mmHg) greater than 5 minutes and 10 minutes was 25.7% and 14.6%, respectively. In another large sample size study of 22,109 patients with ASA grade 3 to 4 undergoing surgery with duration of ≥180 minutes found that 88% of patients experienced at least one episode of intraoperative hypotension, defined as a fall in mean arterial pressure (MAP) below 65 mmHg lasting at least 1 min. A multicenter retrospective cohort study from the U.S. electronic health record database conducted between 2008 and 2017 and including 368222 noncardiac surgeries reported that the incidence of MAP ≤65 mmHg during surgery was 19.3%.
IOH was significantly associated with postoperative complications and poor outcomes. Meta-analysis suggests that IOH increases the incidence of acute kidney injury, myocardial injury, and 30-day mortality after noncardiac surgery. Intraoperative MAP below 70 mmHg is an independent risk factor for increased mortality at 30 days postoperatively, while intraoperative MAP below 65 mmHg is an independent risk factor for myocardial injury after noncardiac surgery. Studies of non-cardiac, non-obstetric surgery have found that intraoperative MAP events below 55 mmHg is associated with persistent renal impairment up to 90 days postoperatively. In addition, intraoperative MAP reductions of more than 30% are associated with postoperative ischemic stroke.
China is experiencing an aging population, the number of elderly patients receiving surgical anesthesia is increasing year by year. Based on the 5-items frailty assessment scale shown that old age is closely related to the development of frailty. The prevalence of frailty among patients over 65-year-old was 7%, and 26% in patients with age over 85 years. Frailty refers to a state in which the functions of multiple systems are cumulatively reduced, leading to a decline in the body's reserve capacity and resistance. Frail patients have decreased organ reserve function, decreased response ability to surgical stress, reduced cardiac stroke volume, impaired cardiac autonomic nervous system function, and decreased albumin levels, resulting in increased blood concentration of anesthetic drugs, at risk for persistent hypotension and severe postoperative complications. In addition, the occurrence of intraoperative hypotension may further aggravate organ dysfunction on the impaired functionality of ischemia-sensitive organs such as the kidneys. The postoperative complications in frail patients undergoing abdominal surgery is as high as 45.5-57.1%. Therefore, it is important to strengthen intraoperative blood pressure management and prevent hypotensive events in frail patients.
IOH is preventable and may potential to improvement in postoperative outcomes. Futier et al highlighted management targeting an individualized systolic blood pressure, compared with standard management, reduced the risk of postoperative organ dysfunction 30 days after surgery. Current treatment of intraoperative hypotensive episodes is not proactive and rather occurs with some delay. For elderly frail populations undergoing major surgery, there is need for a novel method to prevent hypotension.
Edwards Lifesciences has developed an algorithm that by applying machine learning methods analyzing continuously invasively measured arterial waveforms with the Acumen lQ is able to predict hypotension, defined as a mean arterial pressure (MAP) below 65 mmHg lasting for at least 1 min. The Hypotension Prediction Index (HPI) ranges from 0 to 100, and higher values reflect a higher likelihood of hypotension and shorter intervals between periods of hypotension. In major abdominal surgery, HPI demonstrated a sensitivity of 85.8%, 81.7%, and 80.6% respectively to predict a hypotensive event at 5, 10, and 15 minutes before a hypotensive event. The HPI enable the treating anesthetist to proactive treat the predicted hypotension. Various studies have shown that HPI ability in reducing TWA-MAP < 65mmHg and significantly reduction in the incidence of IOH in major noncardiac surgery such as abdominal surgery, gastrointestinal surgery, spinal surgery, in elderly populations undergoing orthopedics surgery.
This study aim to implement intraoperative hemodynamic monitoring and management guided with HPI algorithm in frail patients undergoing elective abdominal surgery. Investigators hypothesize that the use of this algorithm will alter treatment of hypotension and reduces the amount of hypotension as measured by the time weighted average (TWA) during non-cardiac surgery and to anticipate a reduction of postoperative AKI incidents, to explore the clinical benefits of impact of Acumen guided algorithm hemodynamic management in postoperative intestinal function recovery, and postoperative cardiac complications.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Zheng Guan
- Phone Number: 86-13572592715
- Email: guanzheng@xjtufh.edu.cn
Study Locations
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 710061
- The First Affiliated Hospital of Xi'an Jiaotong University
-
Contact:
- Zheng Guan
- Phone Number: +8613572592715
- Email: guanzheng1980@126.com
-
Contact:
- Guan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age> 60 years old
- Frail score > 2
- ASA≥2
- Planned to receive general anesthesia
- Elective laparoscopic or laparotomy major abdominal surgery with an expected duration of > 180 minutes
- Planned to receive an arterial line monitoring intraoperatively
- Being able to give written informed consent prior to surgery
Exclusion Criteria:
- Severe cardiac arrhythmia including atrial fibrillation
- Severe aortic stenosis
- Uncontrolled Hypertension (sitting systolic blood pressure ≥ 160 mmHg and/or diastolic blood pressure ≥100 mmHg during screening)
- Significant hypotension before surgery defined as a MAP <65mmHg
- Chronic kidney disease with glomerular filtration rate <30 ml/min/1.73 m2 or requiring renal-replacement therapy for end-stage renal disease
- Organ transplant surgery, surgery involving the kidney, liver surgery requiring hilar blockage, surgery requiring controlled hypotension or controlled low central venous pressure
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: standard arterial line group
BP, ECG and SpO2 were monitored after entering the operating room, peripheral venous access was established, radial artery puncture catheterization under local anesthesia and connected to TruWave DPT and run data via HemoSphere machine (Edwards Lifesciences).
The target of intraoperative blood pressure was to maintain MAP > 65mmHg.
Timing of treatment and choice of treatment is then left to the discretion of the attending physician.
|
BP, ECG and SpO2 were monitored after entering the operating room, peripheral venous access was established, radial artery puncture catheterization under local anesthesia and connected to TruWave DPT and run data via HemoSphere machine (Edwards Lifesciences).
The target of intraoperative blood pressure was to maintain MAP > 65mmHg.
Timing of treatment and choice of treatment is then left to the discretion of the attending physician.
|
|
Experimental: HPI guided hemodynamic management group
BP, ECG and SpO2 were monitored after entering the operating room, peripheral venous access was established, radial artery puncture catheterization under local anesthesia and connected to the HPI (Edwards Lifesciences). The treating anesthetist is trained to understand Acumen IQ parameters and the meaning of HPI, MAP, CI, SVI, SVR, SVV, Eadyn, dP/dtmax. The treating anesthetist is provided with guidance by means of a flowchart suggesting when to treat and how to treat hypotension. The hemodynamic management is performed according to the HPI guided algorithm. |
BP, ECG and SpO2 were monitored after entering the operating room, peripheral venous access was established, radial artery puncture catheterization under local anesthesia and connected to the HPI (Edwards Lifesciences). The treating anesthetist is trained to understand Acumen IQ parameters and the meaning of HPI, MAP, CI, SVI, SVR, SVV, Eadyn, dP/dtmax. The treating anesthetist is provided with guidance by means of a flowchart suggesting when to treat and how to treat hypotension. The hemodynamic management is performed according to the HPI guided algorithm. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The occurrence of intraoperative hypotension
Time Frame: From anesthesia to end of operation, assessed up to 8 hours.
|
Definition of intraoperative hypotension: MAP< 65mmHg lasting for> 1 minute.
The occurrence of intraoperative hypotension: number of hypotension events, area under the hypotension curve, time-weighted average hypotension, total cumulative time of hypotension, ratio of cumulative total time of hypotension to length of operation
|
From anesthesia to end of operation, assessed up to 8 hours.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidents of AKI
Time Frame: From end of operation to 48 hours after operation, up to 48 hours.
|
Definition of AKI according to KDIGO (Kidney Disease Improving Global Outcomes) criteria: elevated serum creatinine more than 0.3 mg/dl within 48 hours or more than 150% of basal value within 7 days, or urine output < 0.5 ml/kg/hour for more than 6 hours.
The stages of AKI will not be divided.
|
From end of operation to 48 hours after operation, up to 48 hours.
|
|
Intestinal peristalsis recovery time
Time Frame: From end of operation to first bowel movement, assessed up to 48 hours.
|
Auscultation every 4 hours after surgery, and the appearance of ≥4 bowel sounds per minute is considered to be intestinal peristalsis recovery.
|
From end of operation to first bowel movement, assessed up to 48 hours.
|
|
Intestinal function recovery time
Time Frame: From end of operation to first passage of flatus, assessed up to 48 hours.
|
Time from end of operation to first passage of flatus
|
From end of operation to first passage of flatus, assessed up to 48 hours.
|
|
Incidence of myocardiac injury
Time Frame: From end of operation to 7 days after operation, up to 7 days.
|
Presence of ECG changes (bundle branch block, premature beats, or T-wave changes) or cardiographic enlargement or decreased cardiac function, elevated cTn/T >14 pg/ml and/or CK/MB elevated >8.8 ng/ml.
|
From end of operation to 7 days after operation, up to 7 days.
|
|
Incidence of congestive heart failure
Time Frame: From end of operation to 7 days after operation, up to 7 days.
|
Pulmonary edema with clinical or radiographic evidence, requiring diuretic or vasodilator therapy, oxygen saturation less than 93% with or without mechanical ventilation.
|
From end of operation to 7 days after operation, up to 7 days.
|
|
Incidence of acute myocardial infarction
Time Frame: From end of operation to 7 days after operation, up to 7 days.
|
Elevated troponin with at least one of the following: symptoms of myocardial ischemia, new-onset ECG changes (Q-wave formation, left bundle branch block), local ventricular wall motion abnormalities.
|
From end of operation to 7 days after operation, up to 7 days.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mechanical ventilation support time
Time Frame: From anesthesia induction to anesthesia recovery, assessed up to 24 hours.
|
The duration participants underwent mechanical ventilation.
|
From anesthesia induction to anesthesia recovery, assessed up to 24 hours.
|
|
PACU time
Time Frame: From admitted in PACU to discharged from PACU, assessed up to 24 hours.
|
The duration participants admitted in the PACU.
|
From admitted in PACU to discharged from PACU, assessed up to 24 hours.
|
|
ICU time
Time Frame: From admitted in ICU to discharged from ICU, assessed up to 3 days.
|
The duration participants admitted in the ICU
|
From admitted in ICU to discharged from ICU, assessed up to 3 days.
|
|
Hospitalization time
Time Frame: From admission to discharge, assessed up to 15 days.
|
The duration participants in hospitalization.
|
From admission to discharge, assessed up to 15 days.
|
|
Total hospitalization cost
Time Frame: From admission to discharge, assessed up to 15 days.
|
Total expenses during hospitalization.
|
From admission to discharge, assessed up to 15 days.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- XJTU1AF2024LSYY-152
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intraoperative Hypotension
-
University of Hamburg-EppendorfRecruitingIntraoperative HypotensionGermany
-
National and Kapodistrian University of AthensAttikon HospitalRecruiting
-
Tampere University Hospitalgeneral electric healthcare FinlandCompletedIntraoperative Complications | Intraoperative Hypotension | Intraoperative HypertensionFinland
-
Beijing Tsinghua Chang Gung HospitalPeking University People's HospitalNot yet recruitingHemodynamic Instability | Intraoperative HypotensionChina
-
Lanyue ZhuNot yet recruitingIntraoperative Hypotension | Postoperative Acute Kidney InjuryChina
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Edwards LifesciencesCompletedHypotension | Intraoperative Hypotension | Postoperative HypotensionNetherlands
-
Peking Union Medical College HospitalRecruitingIntraoperative HypotensionChina
-
Fondazione IRCCS Policlinico San Matteo di PaviaActive, not recruiting
-
National Taiwan University HospitalNot yet recruitingthe Severity and Duration of Intraoperative Hypotension
-
John Paul II Hospital, KrakowRecruiting
Clinical Trials on standard arterial line
-
The Cleveland ClinicCompletedA Pilot Study to Assess the Accuracy of Blood Pressure Assessment by the Omron HeartGuide SmartwatchHypertension | Surgery | Cardiac DiseaseUnited States
-
Hamad Medical CorporationCompleted
-
National Taiwan University HospitalActive, not recruiting
-
University of IowaTerminated
-
University of California, San DiegoCompletedMedical Device | Feasibility StudyUnited States
-
Temple UniversityCompletedVascular Access ComplicationUnited States
-
Universitair Ziekenhuis BrusselCompleted
-
South Valley UniversityCompletedMajor Abdominal SurgeriesEgypt
-
Instituto Nacional de Cardiologia Ignacio ChavezJOSE CARRASCO ARTEAGA HOSPITAL FROM Ecuadorian Institute of Social SecurityUnknown